Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI

• Status: Enrolling by invitation
• Trial end date: 2022-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The goal of the project is to evaluate osteonecrosis before and after decompression surgery with ferumoxytol-enhanced MRI.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanford University
• Treatments: Ferrosoferric Oxide

Criteria

Inclusion Criteria:

• Osteonecrosis

• planned decompression surgery with autologous stem cell transplant

Exclusion Criteria:

• Contraindications for magnetic resonance imaging

• Hemosiderosis/hemochromatosis ( patients can still be included in the non-ferumoxytol arm)